<DOC>
	<DOC>NCT00678756</DOC>
	<brief_summary>Exploration of antipsoriatic effects of UVB-therapy +/- CYP-inhibitor Ketokonazol on affected psoriatic skin</brief_summary>
	<brief_title>Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dihydroxycholecalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>age: 18 80 diagnosis of psoriasis vulgaris (mild middle) no other current antipsoriatic therapy (systemic/topical) at least 5 psoriatic areas of 5x5 cm pregnancy/nursing mothers women in reproductive age without adequate contraception severe and acute forms of psoriasis vulgaris patients receiving systemic or topical antipsoroatic treatment in past 3 month UVtherapy in past 3 month patients having a positive anamnesis for squamous cell carcinoma, malignant melanoma, basalioma epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Psoriasis vulgaris,</keyword>
	<keyword>vitamin D, UVB-phototherapy, ketokonazol,</keyword>
	<keyword>Optical Coherence Tomography,</keyword>
	<keyword>local PASI, Nizoral</keyword>
</DOC>